Related-Party Transactions - Additional Information (Details) - USD ($) |
12 Months Ended | ||
---|---|---|---|
Dec. 31, 2019 |
Dec. 31, 2018 |
Dec. 31, 2017 |
|
Related Party Transaction [Line Items] | |||
Revenue from related parties | $ 22,536,000 | $ 18,966,000 | $ 44,606,000 |
Receivables from agreement | 6,298,000 | 2,489,000 | |
Celgene | |||
Related Party Transaction [Line Items] | |||
Revenue from related parties | 8,900,000 | ||
SutroVax | |||
Related Party Transaction [Line Items] | |||
Receivables from agreement | $ 14,000 | $ 49,000 | |
Percentage common stock ownership interest | 5.60% | 5.60% | |
Carrying value of common stock under the cost method | $ 0 | $ 0 | |
Sutro Biopharma | Celgene | Minimum | IPO | |||
Related Party Transaction [Line Items] | |||
Equity interest percentage | 10.00% | ||
Sutro Biopharma | Celgene | Maximum [Member] | IPO | |||
Related Party Transaction [Line Items] | |||
Equity interest percentage | 10.00% | ||
Sutro Biopharma | Merck | |||
Related Party Transaction [Line Items] | |||
Equity interest percentage | 11.80% | 11.90% |
X | ||||||||||
- Definition Carrying value of common stock. No definition available.
|
X | ||||||||||
- Definition Common stock ownership percentage. No definition available.
|
X | ||||||||||
- Definition Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition The equity interest of noncontrolling shareholders, partners or other equity holders in consolidated entity. No definition available.
|
X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. No definition available.
|
X | ||||||||||
- Definition Amount of revenue, fees and commissions earned from transactions between (a) a parent company and its subsidiaries; (b) subsidiaries of a common parent; (c) an entity and trusts for the benefit of employees, for example, but not limited to, pension and profit-sharing trusts that are managed by or under the trusteeship of the entity's management; (d) an entity and its principal, owners, management, or members of their immediate families; and (e) affiliates. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|